Iron‐dexamethasone nanoparticles mitigate acute neutrophilic inflammation
Open Access
- 19 August 2026
- journal article
- research article
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 11 (6) , e70173
Abstract
Neutrophils are the primary immune cell type present within the blood and the first to arrive at sites of inflammation. As such, neutrophils set the stage for how the inflammatory response progresses and resolves. In some cases of non‐resolving inflammation, excessive neutrophil accumulation can cause tissue damage. Accordingly, maintaining tight control over their recruitment and behavior at sites of inflammation is paramount. Historically, corticosteroids have been used to modulate inflammation, but they are associated with systemic side effects that have limited their use. Here, we developed an iron‐dexamethasone nanoparticle (DexOx NP) therapeutic that modulates neutrophil behavior and reroutes neutrophils away from sites of inflammation. DexOx NPs inhibit neutrophil activation, as indicated by prevention of L‐selectin shedding and reduced neutrophil extracellular trap formation. Furthermore, treatment with DexOx NPs in a murine acute lung injury model significantly reduced the total number of neutrophils in the bronchoalveolar lavage fluid while avoiding the side effects of systemic soluble dexamethasone phosphate delivery. Thus, DexOx NPs represent a new option to control non‐resolving neutrophilic inflammation.Keywords
Funding Information
- National Institute of General Medical Sciences (T32GM145304)
This publication has 44 references indexed in Scilit:
- Rod‐shaped Polymerized Salicylic Acid Particles Modulate Neutrophil Transendothelial Migration in Acute InflammationAdvanced Healthcare Materials, 2025
- Polymerized Salicylic Acid Microparticles Reduce the Progression and Formation of Human Neutrophil Extracellular Traps (NET)sAdvanced Healthcare Materials, 2024
- Interaction between iron oxide nanoparticles (Fe3O4 NPs) and human neutrophils: Evidence that Fe3O4 NPs possess some pro-inflammatory activitiesChemico-Biological Interactions, 2022
- The Epidemiology of Acute Respiratory Distress Syndrome Before and After Coronavirus Disease 2019Critical Care Clinics, 2021
- Recent advances in the formulation of PLGA microparticles for controlled drug deliveryProgress in Biomaterials, 2020
- A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs TherapeuticsClinical Reviews in Allergy & Immunology, 2020
- Pharmaceutical compatibility of dexamethasone with excipients commonly used in solid oral dosage formsJournal of Thermal Analysis and Calorimetry, 2020
- Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsisIntensive Care Medicine, 2020
- PEGylation of model drug carriers enhances phagocytosis by primary human neutrophilsActa Biomaterialia, 2018
- Neutrophils in innate and adaptive immunitySeminars in Immunopathology, 2013